Patient Safety & Outcomes Archives - Page 189 of 334 - Becker's Hospital Review

Yale children's hospital launches long COVID-19 program

Yale New Haven (Conn.) Children's Hospital has launched a post-COVID-19 program for teens and children still experiencing effects weeks or months after the infection, according to a news release shared with Becker's May 28.

45% of COVID-19 patients leave hospital with functional decline, Michigan Medicine finds

Nearly half of COVID-19 patients discharged from Ann Arbor-based Michigan Medicine last spring experienced functional decline, research shows.

72% of COVID-19 survivors have persistent symptoms, study finds

Nearly three-fourths of people who recover from COVID-19 have at least one lingering symptom, according to a study published May 26 in Jama Network Open.

Kansas hospital restores operations after generator problem

Geary Community Hospital resumed operations after a generator problem led the Junction City, Kan.-based hospital to transfer all of its patients and pause some services.

Early enteral nutrition can mean the difference between thriving and surviving for the critically ill

Amid the COVID-19 pandemic, food insecurity among Americans has grown significantly. When malnourished individuals are hospitalized with critical illnesses, many face increased health risks and negative outcomes. Early enteral nutrition can help by maintaining the lean body mass and muscle…

Physicians should help patients maintain a healthy weight during pregnancy, US task force says

Physicians should offer pregnant women counseling to support them in maintaining a healthy weight throughout pregnancy, the U.S. Preventive Services Task Force said in updated guidance released May 25.

Arizona revises crisis standards of care after federal complaint

Arizona revised guidelines on allocating scarce medical resources during crises such as the COVID-19 pandemic to resolve a federal complaint filed last summer, the HHS Office of Civil Rights said May 25.

Roche's arthritis drug linked to lower death rates for COVID-19 patients, study finds

Roche's rheumatoid arthritis drug tocilizumab was linked to a lower risk of death 90 days after treatment in patients with moderate to severe COVID-19 or pneumonia, especially patients with high C-reactive protein levels, according to a May 24 JAMA Internal…

Severe MIS-C symptoms appear to resolve within 6 months, study suggests

The most severe symptoms of multisystem inflammatory syndrome in children — a rare but serious condition related to COVID-19 — resolved within six months for most patients, though less debilitating symptoms lingered for some, according to a small study published…

Community health workers linked to lower hospital readmissions

An intervention program that paired community health workers with patients led to a drop in 30-day hospital readmissions, according to clinical trial results published May 20 in JAMA Network Open.